The authors demonstrated that the levels of mTOR, phospho-m-TOR, and mitogen-activated kinase p-P70S6K proteins decreased after metformin treatment of breast cancer cells resistant to tamoxifen. The gene discussed is MTOR; the disease is breast carcinoma.